Investor Overview
News
- Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal AntibodySeptember 16, 2020 8:03 AM EDT
- Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth ConferenceSeptember 9, 2020 8:02 AM EDT
- Kindred Biosciences Announces Second Quarter 2020 Financial ResultsAugust 5, 2020 4:02 PM EDT
Events
- Thursday, September 17, 2020
- Wednesday, September 16, 2020 from 2:40 PM to 3:10 PM EDT
- Tuesday, September 15, 2020 from 3:30 PM to 3:50 PM EDT
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Investor Overview
KindredBio is focused on bringing innovative biologics and technologies to veterinary medicine to address unmet clinical needs and provide benefits to pets.
Stock Information
News
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody
September 16, 2020
- Study demonstrated 100% efficacy in prevention of parvovirus infection in proph...
Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference
September 9, 2020
SAN FRANCISCO , Sept. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Second Quarter 2020 Financial Results
August 5, 2020
SAN FRANCISCO , Aug. 5, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...